Ben-Shlomo, Y, Head, J, Lees, AJ. Mortality in DATATOP. Annal Neurol. 1999;45:138-139.
Chen, H, Zhang, SM, Schwarzschild, MA, Hernan, MA, Ascherio, A. Survival of Parkinson’s disease patients in a large prospective cohort of male health professionals. Mov Disord. 2006;21:1002-1007.
Auyeung, M, Tsoi, TH, Mok, V, et al. Ten year survival and outcomes in a prospective cohort of new onset Chinese Parkinson’s disease patients. J Neurol Neurosurg Psychiatry. 2012;83:607-611.
Diem-Zangerl, A, Seppi, K, Wenning, GK, et al. Mortality in Parkinson’s disease: a 20-year follow-up study. Mov Disord. 2009;24:819-825.
Hely, MA, Morris, JG, Traficante, R, Reid, WG, O’Sullivan, DJ, Williamson, PM. The Sydney multicentre study of Parkinson’s disease: progression and mortality at 10 years. J Neurol Neurosurg psychiatry. 1999;67:300-307.
Mylne, AQ, Griffiths, C, Rooney, C, Doyle, P. Trends in Parkinson’s disease related mortality in England and Wales, 1993-2006. Eur J Neurol. 2009;16:1010-1016.
Posada, IJ, Benito-Leon, J, Louis, ED, et al. Mortality from Parkinson’s disease: a population-based prospective study (NEDICES). Mov Disord. 2011;26:2522-2529.
Ben-Shlomo, Y, Marmot, MG. Survival and cause of death in a cohort of patients with parkinsonism: possible clues to aetiology?
J Neurol Neurosurg Psychiatry. 1995;58:293-299.
Hughes, TA, Ross, HF, Mindham, RH, Spokes, EG. Mortality in Parkinson’s disease and its association with dementia and depression. Acta Neurol Scand. 2004;110:118-123.
Herlofson, K, Lie, SA, Arsland, D, Larsen, JP. Mortality and Parkinson disease: A community based study. Neurology. 2004;62:937-942.
Ishihara, LS, Cheesbrough, A, Brayne, C, Schrag, A. Estimated life expectancy of Parkinson’s patients compared with the UK population. J Neurol Neurosurg Psychiatry. 2007;78:1304-1309.
Mortality in DATATOP: a multicenter trial in early Parkinson’s disease. Parkinson Study Group. Ann Neurol. 1998;43:318-325.
Wang, G, Hong, Z, Cheng, Q, et al. Validation of the Chinese non-motor symptoms scale for Parkinson’s disease: results from a Chinese pilot study. Clin Neurol Neurosurg. 2009;111:523-526.
Wang, G, Cheng, Q, Zeng, J, et al. Sleep disorders in Chinese patients with Parkinson’s disease: validation study of a Chinese version of Parkinson’s disease sleep scale. J Neurol Sci. 2008;271:153-157.
Chen, W, Chen, S, Kang, WY, et al. Application of odor identification test in Parkinson’s disease in China: a matched case-control study. J Neurol Sci. 2012;316:47-50.
Wang, G, Cheng, Q, Zheng, R, et al. Economic burden of Parkinson’s disease in a developing country: a retrospective cost analysis in Shanghai, China. Mov Disord. 2006;21:1439-1443.
World Heath Organization. Manual of the international classification of disease injuries and causes of death 9th revision. Geneva: World Health Organization; 1978.
Chen, W, Chen, S, Xiao, Q, Wang, G, Chen, SD. Current clinical practice for Parkinson’s disease among Chinese physicians, general neurologists and movement disorders specialists: a national survey. BMC Neurol. 2012;12:155.
Hely, MA, Morris, JG, Reid, WG, Trafficante, R. Sydney Multicenter Study of Parkinson’s disease: non-L-dopa-responsive problems dominate at 15 years. Mov Disord. 2005;20:190-199.
Pennington, S, Snell, K, Lee, M, Walker, R. The cause of death in idiopathic Parkinson’s disease. Parkinsonism Rel Disord. 2010;16:434-437.
Monteiro, L, Souza-Machado, A, Pinho, P, Sampaio, M, Nobrega, AC, Melo, A. Swallowing impairment and pulmonary dysfunction in Parkinson’s disease: The silent threats. J Neurol Sci. 2014;339:149-152.
Chen, W, Xu, ZM, Wang, G, Chen, SD. Non-motor symptoms of Parkinson’s disease in China: a review of the literature. Parkinsonism Rel Disord. 2012;18:446-452.
de Lau, LM, Verbaan, D, Marinus, J, van Hilten, JJ. Survival in Parkinson’s disease. Relation with motor and non-motor features. Parkinsonism Rel Disord. 2014;20:613-616.
Xu, J, Gong, DD, Man, CF, Fan, Y. Parkinson’s disease and risk of mortality: meta-analysis and systematic review. Acta Neurol Scand. 2014;129:71-79.
Aarsland, D, Zaccai, J, Brayne, C. A systematic review of prevalence studies of dementia in Parkinson’s disease. Mov Disord. 2005;20:1255-1263.
Irwin, DJ, Lee, VM, Trojanowski, JQ. Parkinson’s disease dementia: convergence of alpha-synuclein, tau and amyloid-beta pathologies. Nat Rev Neurosci. 2013;14:626-636.
Chen, HL, Zhao, EJ, Zhang, W, et al. Meta-analyses on prevalence of selected Parkinson’s nonmotor symptoms before and after diagnosis. Transl Neurodegener. 2015;4:1.
Gjerstad, MD, Alves, G, Wentzel-Larsen, T, Aarsland, D, Larsen, JP. Excessive daytime sleepiness in Parkinson disease: is it the drugs or the disease?
Zhu, K, van Hilten, JJ, Marinus, J. Predictors of dementia in Parkinson’s disease; findings from a 5-year prospective study using the SCOPA-COG. Parkinsonism Rel Disord. 2014;20:980-985.